ICON
The Integrated Study Timeline Implementation Manager leads the development, customization, and maintenance of Integrated Study Timelines (IST) for clinical trials, working exclusively with a pharmaceutical client. The role partners with Global Trial Leads and cross-functional stakeholders to monitor, update, and ensure timeline alignment across the study lifecycle.
Headquarters
Austin, Texas, United States
Company Size
201-500 employees
Founded
2017
ICON develops advanced construction technologies—large‑scale 3D printing robotics, proprietary software, and engineered materials—to accelerate and democratize building. The company supplies hardware, software and integrated construction services for homes and infrastructure, partnering with developers, governments and humanitarian organizations to deliver faster, lower‑cost, resilient structures. By automating construction and optimizing materials, ICON reduces labor, waste and build time while enabling new designs and scalable community solutions.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for ICON.
ICON didn’t post a salary, so this is our estimate from similar listings.
ICON launches Titan printer rollout for construction companies
2 days ago
Integrated Study Timeline Manager
ICON plc
Single Sponsor Clinical Trial Manager / Local Study Manager - fully home based - UK only
Syneos Health
Global Study Manager II - Poland/Spain/Serbia/Romania - FSP
Parexel
Regional Study Coordinator
Labcorp
Clinical Study Specialist
Regeneron Pharmaceuticals
Clinical Study Manager
Global Channel Management